Emergency surgery in acute coronary syndrome

Similar documents
What do the guidelines say?

Appropriate Timing for Coronary Revascularization Post - MI. Manesh R. Patel, MD Assistant Professor of Medicine Duke University Medical Center

'Coronary artery bypass grafting in patients with acute coronary syndromes: perioperative strategies to improve outcome'

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Declaration of conflict of interest NONE

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Cardiogenic Shock. Carlos Cafri,, MD

A case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

Non ST Elevation-ACS. Michael W. Cammarata, MD

SUPPLEMENTAL MATERIAL

CABG Surgery following STEMI

Management of Cardiogenic shock. Prof. Christian JM Vrints

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG

Ischemic Mitral Valve Disease: Repair, Replace or Ignore?

Ted Feldman, M.D., MSCAI FACC FESC

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting

J. Schwitter, MD, FESC Section of Cardiology

Surgery Grand Rounds

TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA. IMP v4

The Case for Multivessel Revascularization in Shock

Alex versus Xience Registry Preliminary report

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute

Cindy L. Grines MD FACC FSCAI

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011

Ischemic Heart Disease Interventional Treatment

PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece

Ischemic Mitral Regurgitation

PUMP FAILURE COMPLICATING AMI: ISCHAEMIC VSR

STEMI AND MULTIVESSEL CORONARY DISEASE

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction

Ischemic Heart Disease Interventional Treatment

Approach to Multi Vessel disease with STEMI

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?

Acute Coronary Syndromes

DECLARATION OF CONFLICT OF INTEREST

Dual Antiplatelet Therapy Made Practical

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

Common Codes for ICD-10

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Recovering Hearts. Saving Lives.

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines)

Acute Coronary Syndrome. Sonny Achtchi, DO

Controversies in Cardiac Pharmacology

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24.

Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017

Introduction to Acute Mechanical Circulatory Support

Minimally invasive direct coronary artery bypass for left anterior descending artery revascularization analysis of 300 cases

Cardiogenic Shock in Acute MI

DECLARATION OF CONFLICT OF INTEREST

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention

PRASUGREL HYDROCHLORIDE (Effient Eli Lilly Canada Inc.) Indication: Acute Coronary Syndrome

IABP SHOCK II trial:

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

How to Perform Hybrid Myocardial Revascularisation: Interventional Perspective

Cardiogenic Shock and Initiatives to Reduce Mortality

Patients in whom PCI is preferred over CABG _ Aleksander Ernst Clinical Hospital Center Zagreb University of Zagreb School of Medicine Zagreb, CROATIA

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery

Cardiovascular Health Nova Scotia Update to Antiplatelet Sections of the Nova Scotia Guidelines for Acute Coronary Syndromes, 2008.

Out-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland

Update interventional Cardiology Hans Rickli St.Gallen

TYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Chronic Total Occlusion: a case for coronary artery bypass grafting

Assist Devices in STEMI- Intra-aortic Balloon Pump

COAGULATION, BLEEDING, AND TRANSFUSION IN URGENT AND EMERGENCY CORONARY SURGERY

Timing of Surgery After Percutaneous Coronary Intervention

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing

Myocardial Infarction In Dr.Yahya Kiwan

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

Repair or Replacement

Antonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017

DECLARATION OF CONFLICT OF INTEREST. Lecture fees: AstraZeneca, Ely Lilly, Merck.

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Adults With Diagnosed Diabetes

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None

Unprotected LM intervention

Le# Main Interven-on: When Is It Appropriate. Femi Philip, MD Assistant Professor Of Medicine UC Davis

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines)

Management of High-Risk CAD : Surgeons Perspective

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

Results and Treatment Strategy for Patients Undergoing Emergent Coronary Artery Bypass Grafting

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?

REVISED MI DEFINITIONS IMPLICATIONS FOR CLINICAL TRIALS. Maarten L Simoons Thoraxcenter - Erasmus MC Rotterdam - The Netherlands

Οξύ στεφανιαίο σύνδρομο και καρδιογενής καταπληξία. Επεμβατική προσέγγιση. Σωτήριος Πατσιλινάκος Κωνσταντοπούλειο Γ.Ν. Ν. Ιωνίας

Treatment Options for Angina

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Coronary artery surgery results In The Survey Committee of Japanese Association for Coronary Artery Surgery (JACAS)

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

Management of cardiovascular disease - coronary interventions -

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

Transcription:

Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Acute coronary syndrome a spectrum of conditions compatible with acute myocardial ischemia and/or infarction that are usually due to an abrupt reduction in coronary blood flow Amsterdam et al 2014 AHA/ACC NSTE-ACS Guideline

Acute coronary syndrome Amsterdam et al 2014 AHA/ACC NSTE-ACS Guideline

Epidemiology Over seven million people every year die from CAD, 12.8% of all deaths (WHO 2011) 1.5 million hospital admissions in the U.S. annually: Approximately 70% NSTE-ACS ; (Heart Disease and Stroke Statistics-2014 Update from AHA) In the Europe (incidence per 100,000/year) : 77 STEMI, 132 non-stemi (ESC guideline 2012)

39 participating medical centers.(22 open heart surgery) Between October 2007 and December 2008, 2,007 patients were enrolled. 55% STEMI 33% NSTEMI 12% UA. J Med Assoc Thai Vol. 95 No. 4 2012

J Med Assoc Thai Vol. 95 No. 4 2012

Emergency CABG : 2003-2013 3.6% of total CABG

The society of thoracic surgeon of Thailand : 2014-2015 statistic Siriraj Isolated CABG 842 Total CABG 1,059 Emergency CABG 18 (2.1%) 67 hospitals Isolated CABG 8,628 Total CABG 10,472 Emergency CABG ~ 172-258??

What is an emergency? Immediate Within 12 hrs Within 24 hrs Within 48 hrs early strategy Guideline??? Surgeon and Heart team

Indication Class I Recommendations (Level of Evidence: B) 1. acute MI in whom 1) primary PCI has failed or cannot be performed 2) coronary anatomy is suitable for CABG, and 3) persistent ischemia of a significant area of myocardium at rest and/or hemodynamic instability refractory to nonsurgical therapy is present Hillis et al 2011 ACCF/AHA CABG Guideline

Indication Class I Recommendations (Level of Evidence: B) 2. Patients undergoing surgical repair of a post infarction mechanical complication of MI ventricular septal rupture mitral valve insufficiency because of papillary muscle infarction and/or rupture free wall rupture Hillis et al 2011 ACCF/AHA CABG Guideline

Indication Class I Recommendations (Level of Evidence: B) 3. Patients with cardiogenic shock and who are suitable for CABG irrespective of the time interval from MI to onset of shock and time from MI to CABG. Hillis et al 2011 ACCF/AHA CABG Guideline

Indication Class I Recommendations (Level of Evidence: C) 4. Patients with life-threatening ventricular arrhythmias (believed to be ischemic in origin) in the presence of left main stenosis greater than or equal to 50% and/or 3-vessel CAD Hillis et al 2011 ACCF/AHA CABG Guideline

Indication Class IIa Recommendations (Level of Evidence: B) 1. Patients with multivessel CAD with recurrent angina or MI within the first 48 hours of STEMI presentation as an alternative to a more delayed strategy. Hillis et al 2011 ACCF/AHA CABG Guideline

Indication Class III Recommendations (Level of Evidence: C) 1. Emergency CABG should not be performed in patients with persistent angina and a small area of viable myocardium who are stable hemodynamically. 2. Emergency CABG should not be performed in patients with no reflow (successful epicardial reperfusion with unsuccessful microvascular reperfusion). Hillis et al 2011 ACCF/AHA CABG Guideline

Emergency CABG After Failed PCI Failed PCI abrupt vessel closure extensive coronary artery dissection incomplete revascularization coronary perforation Unsuccessful dilation other situations resulting in hemodynamic instability and requiring surgical intervention Yang et al. 2005 JACC Vol. 46, No. 11

Emergency CABG After Failed PCI Recommendations Class I level of evidence B 1. Emergency CABG is recommended after failed PCI in the presence of ongoing ischemia or threatened occlusion with substantial myocardium at risk. 2. Emergency CABG is recommended after failed PCI for hemodynamic compromise in patients without impairment of the coagulation system and without a previous sternotomy.

Emergency CABG After Failed PCI Recommendations Class IIa level of evidence C 1. Emergency CABG is reasonable after failed PCI for retrieval of a foreign body (most likely a fractured guidewire or stent) in a crucial anatomic location. 2. Emergency CABG can be beneficial after failed PCI for hemodynamic compromise in patients with impairment of the coagulation system and without previous sternotomy.

Emergency CABG After Failed PCI Recommendation Class IIb Level of Evidence: C 1. Emergency CABG might be considered after failed PCI for hemodynamic compromise in patients with previous sternotomy.

Emergency CABG After Failed PCI Recommendation Class III Level of Evidence: C 1. Emergency CABG should not be performed after failed PCI in the absence of ischemia or threatened occlusion. 2. Emergency CABG should not be performed after failed PCI if revascularization is impossible because of target anatomy or a no-reflow state.

Timing NSTE-ACS In a large database analysis of unselected patients admitted for ACS, performance of early CABG(< 48 hrs), even in higher-risk patients, was associated with low in-hospital mortality. STEMI (Monteiro P. Circulation 2006;114), (Parikh SV. JACC Cardiovasc Interv 2010;3(4) When possible, in the absence of persistent pain or haemodynamic deterioration, a waiting period of 3 7 days appears the best compromise. (Weiss ES, J Thorac Cardiovasc Surg 2008;135(3) In patients referred for urgent CABG, clopidogrel and ticagrelor should be discontinued for at least 24 hours to reduce major bleeding complications. Class I recommendation (Hillis et al 2011 ACCF/AHA CABG Guideline)

Surgical technique Conventional CABG On pump beating heart OPCAB

Surgical technique myocardial oxygen demand CPB related inflammatory injury Conventional CABG Global ischemia On pump beating heart - OPCAB - - -

638 (3.3%) (stable 531, CS 107) 240 Beating heart operation 124 OPCAB 116 on pump beating heart 398 conventional CPB/CA Rastan et al.beating Heart CABG in Emergency ACS, Circulation July 4, 2006

Rastan et al. Beating Heart CABG in Emergency ACS, Circulation July 4, 2006

Stable hemodynamic CA is superior in Shorter CPB time More distal anastomoses Cx territory grafting BH is superior in Time to culprit lesion revascularization

BH is superior in less Inotrope less bleeding less hospital stay

Follow up median 2.78 years (range 0.02 to 5.86 years)

Follow up median 2.78 years (range 0.02 to 5.86 years)

Between January 1996 and March 2003 614 patients 44 (7%) OPCAB (acceptable hemodynamics) 570 (83%) CABG/CPB KERENDI ET AL Ann Thorac Surg EMERGENCY OFF-PUMP CORONARY BYPASS 2005;79:801 6

KERENDI ET AL Ann Thorac Surg EMERGENCY OFF-PUMP CORONARY BYPASS 2005;79:801 6

KERENDI ET AL Ann Thorac Surg EMERGENCY OFF-PUMP CORONARY BYPASS 2005;79:801 6

Conventional CABG Myocardial protection Antegrade Retrograde Graft Adequate vent Optimal revascularization and clamp time Conduit Perioperative care and support

Mechanical Hemodynamic support 38% of patients need Intra aortic balloon pump 3%-10% of patients need Extracorporeal Membrane Oxygenator (ECMO) HAGL ET AL. Ann Thorac Surg 2009;88:1786 92

Results and prognosis 30 days or in hospital Mortality rate : 6.6% - 32% 1- year survival : ~ 70% 3- year survival : ~ 60% 5- year survival : ~ 50% STEMI, PVD, DM, lactate levels >4mmol/l and high preoperative inotrope, and ECMO support predicted late mortality. Piroze M Davierwala et al,nov;2005

Conclusion The Incidence of emergency CABG decrease. The mortality rate associated with emergency CABG remains high and unchanged. Beating heart coronary artery bypass graft maybe improve the outcome but maybe not suitable for the instable patients and LM disease. If the ACS patients need CABG and can wait, wait!!!

Thank you for your attention